Cargando…
A Thoroughly Validated Virtual Screening Strategy for Discovery of Novel HDAC3 Inhibitors
Histone deacetylase 3 (HDAC3) has been recently identified as a potential target for the treatment of cancer and other diseases, such as chronic inflammation, neurodegenerative diseases, and diabetes. Virtual screening (VS) is currently a routine technique for hit identification, but its success dep...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297770/ https://www.ncbi.nlm.nih.gov/pubmed/28106794 http://dx.doi.org/10.3390/ijms18010137 |